Purple Biotech (PPBT) Earnings Date, Estimates & Call Transcripts $2.13 -0.02 (-0.93%) Closing price 04:00 PM EasternExtended Trading$2.12 0.00 (-0.23%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Purple Biotech Earnings Summary Purple Biotech posted Q2 2025 earnings on August 6, 2025, reporting an EPS of -$0.40, which missed the consensus estimate of -$0.21 by $0.19. With a trailing EPS of -$0.42, Purple Biotech's earnings are expected to decrease next year, from ($0.83) to ($1.65) per share. Q2 2025 Earnings ResourcesQ2 2025 Earnings ReportPPBT Upcoming EarningsPurple Biotech's next earnings date is estimated for Friday, August 15, 2025, based on past reporting schedules. Upcoming Q3 Earnings DateAug. 15Before Market OpensEstimatedConsensus EPS (Aug. 6) -$0.21 Actual EPS (Aug. 6) -$0.40 Missed By -$0.19 Get Purple Biotech Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Purple Biotech and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataPPBT Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Purple Biotech Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ2 20251-$0.21-$0.21-$0.21Q3 20251-$0.26-$0.26-$0.26Q4 20251-$0.52-$0.52-$0.52 Purple Biotech Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/15/2025(Estimated)--------8/6/2025Q2 2025-$0.21-$0.40 -$0.19-$0.40--5/21/2025Q1 2025--$0.17--$0.17--3/10/2025Q4 2024-$0.22-$0.26 -$0.04-$0.26--8/16/2024Q2 2024-$2.60-$1.60+$1.00-$0.07--5/21/2024Q1 2024-$3.00-$3.20 -$0.20-$0.18--3/5/2024Q4 2023-$3.40-$6.40 -$3.00-$0.45--11/21/2023Q3 2023-$4.60-$4.60--$0.23--8/22/2023Q2 2023-$5.20-$5.00+$0.20-$0.25-- Purple Biotech Earnings - Frequently Asked Questions When is Purple Biotech's earnings date? Purple Biotech has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, August 15th, 2025 based off last year's report dates. Learn more on PPBT's earnings history. Did Purple Biotech beat their earnings estimates last quarter? In the previous quarter, Purple Biotech (NASDAQ:PPBT) missed the analysts' consensus estimate of ($0.21) by $0.19 with a reported earnings per share (EPS) of ($0.40). Learn more on analysts' earnings estimate vs. PPBT's actual earnings. How much profit does Purple Biotech generate each year? Purple Biotech (NASDAQ:PPBT) has a recorded net income of -$7.24 million. PPBT has generated -$0.42 earnings per share over the last four quarters. What is Purple Biotech's EPS forecast for next year? Purple Biotech's earnings are expected to decrease from ($0.83) per share to ($1.65) per share in the next year. More Earnings Resources from MarketBeat Related Companies Aytu BioPharma Earnings Passage Bio Earnings Dare Bioscience Earnings Lisata Therapeutics Earnings Reviva Pharmaceuticals Earnings Cadrenal Therapeutics Earnings Natural Alternatives International Earnings VYNE Therapeutics Earnings Elevation Oncology Earnings Relmada Therapeutics Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Dutch Bros Just Flipped the Script With a Massive Earnings BeatIs Eli Lilly’s 14% Post-Earnings Slide a Buy-the-Dip Opportunity?Constellation Energy’s Earnings Beat Signals a New EraRealty Income Rallies Post-Earnings Miss—Here’s What Drove ItDon't Mix the Signal for Noise in Super Micro Computer's EarningsWhy Monolithic Power's Earnings and Guidance Ignited a RallyRivian Takes Earnings Hit—R2 Could Be the Stock's 2026 Lifeline This page (NASDAQ:PPBT) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredSell this, buy thatWhat you don’t own matters just as much as what you do. That’s the thinking behind Eric Fry’s long-time strate...InvestorPlace | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredFormer CIA Officer Reveals How Gold Saved His Life This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Purple Biotech Ltd. Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Purple Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
